Schizophrenia And Sleep: Understanding The Complex Relationship

Sleep disturbances are a common symptom of schizophrenia, with up to 80% of people with the condition experiencing some form of sleep difficulty. These disturbances can manifest in various ways, including insomnia, hypersomnia, and irregular sleep-wake patterns. People with schizophrenia may sleep too little or too much, and their sleep patterns may not align with the typical sleep-wake cycle of sleeping at night and being awake during the day.

The link between schizophrenia and sleep problems is a growing area of research. Sleep disturbances are often one of the first symptoms of schizophrenia to appear, even before the onset of psychosis. They can also be a sign of relapse or worsening of symptoms. Poor sleep can negatively impact the everyday functioning and social activities of individuals with schizophrenia, which are already significantly impacted by the condition. Additionally, sleep problems can lead to other health issues, such as a weakened immune system and a higher risk of diabetes.

There are several possible explanations for the connection between schizophrenia and sleep disturbances. One factor may be changes in neurobiology due to the condition, which can alter sleep physiology. Another factor could be the medications used to treat schizophrenia, as some antipsychotic drugs can cause weight gain, increasing the risk of sleep apnea. Additionally, the dysfunction of dopamine D2 receptors, which are linked to increased wakefulness and insomnia, may play a role in sleep disturbances in schizophrenia.

Treating sleep disorders in individuals with schizophrenia is important for managing the condition effectively. Cognitive-behavioral therapy (CBT) and certain medications, such as antipsychotics and non-addictive sleep aids like melatonin, can help improve sleep quality. Additionally, lifestyle changes, such as improving sleep hygiene, limiting caffeine intake, and maintaining a regular sleep schedule, can also contribute to better sleep.

Circadian rhythm disruption

Research has suggested that gene mutations could be a potential cause of circadian rhythm disruptions in people with schizophrenia. Specifically, the CLOCK (circadian locomotor output cycles kaput) gene, which influences the regulation of circadian cycles, has been implicated. This disruption can lead to abnormal sleep patterns, such as sleeping during the day and staying awake at night.

The impact of circadian rhythm disruption can be significant. It can affect an individual's physical and mental health, causing complications such as a weakened immune system and a higher risk for diabetes. Additionally, it can worsen the symptoms of schizophrenia, including disorganised thought, difficulty concentrating, and difficulty expressing thoughts.

Treating sleep disorders in people with schizophrenia is crucial. Cognitive-behavioural therapy (CBT) has been found to be beneficial in helping individuals manage sleep disruptions. Medications, such as antipsychotics and non-stimulant sleeping pills, can also be prescribed to improve sleep quality. However, it is important to note that some medications may have side effects or be addictive.

Insomnia

Dopamine is a brain chemical that your body uses to send signals between nerve cells. It affects your mood, memory, coordination, and other important functions. When dopamine receptors are overactive, it can cause insomnia. This is because dopamine needs to be at the right level for these functions to work correctly.

In addition to insomnia, people with schizophrenia may also experience other sleep disturbances, such as hypersomnia, irregular sleep-wake patterns, and circadian rhythm disorders. These sleep disturbances can impact a person's physical and mental health, making it difficult to manage their schizophrenia symptoms.

Treating sleep disorders is an important part of managing schizophrenia. Cognitive-behavioural therapy (CBT) has been shown to be helpful for people with schizophrenia who are struggling with sleep disruptions. Medications, such as antipsychotics and non-stimulant sleeping pills, can also be used to treat insomnia in people with schizophrenia. However, it is important to note that some medications may be addictive or interfere with schizophrenia medication.

Obstructive sleep apnea

OSA is associated with severe adverse health outcomes, including impaired cardiovascular health, weight gain, diabetes, cognitive impairment, and reduced quality of life. It is also linked to the development of physical health comorbidities such as diabetes, cardiovascular and respiratory diseases, and to a greater severity of psychiatric symptoms in people with schizophrenia.

The most effective treatment for OSA is continuous positive airway pressure (CPAP) therapy, which utilizes a mask applied to the nose and/or mouth to deliver air pressure to the upper airway and prevent airway collapse during sleep. CPAP has been shown to reduce the risk of metabolic syndrome, improve cardiovascular outcomes and daytime function, and is associated with large healthcare economic benefits.

Despite the potential benefits of CPAP, studies reporting on the diagnosis and treatment of OSA in people with schizophrenia are rare. This may be due to a lack of awareness of OSA and routine screening for apnea symptoms in mental health settings. Additionally, there is a notion that amotivation, poor adherence, or lack of tolerance in people with schizophrenia may lead to treatment failure.

However, research has shown that CPAP is feasible and effective in treating OSA in people with schizophrenia and that antipsychotic medications are not a barrier to treatment response. In a large-scale study, individuals with schizophrenia who were referred for a CPAP trial showed similar CPAP trial acceptance and completion rates compared to a non-psychiatric control group. They were also no less adherent to CPAP and gained significant symptom relief from CPAP, indicating that CPAP is a viable treatment option for OSA in this population.

Dopamine dysfunction

Dopamine is a brain chemical that your body uses to send signals between nerve cells. It affects your mood, memory, coordination, and other important functions. For dopamine to work correctly, it needs to be at the right level. Both high and low levels of dopamine can impact how your body works.

High dopamine activity is linked to several mental health conditions, including insomnia and schizophrenia. As both insomnia and schizophrenia are linked to high dopamine levels, it can be difficult for people with schizophrenia to manage insomnia and get restful sleep. Research from 2017 suggests that dysfunction of dopamine D2 receptors may influence the positive symptoms of schizophrenia as well as sleep problems.

The dysfunction causes the dopamine receptors to be overactive. This is linked to many of the symptoms of schizophrenia, including sleep disruption. The overactivity of D2 receptors in the brain's striatum has been linked to the positive symptoms of schizophrenia and may also cause increased wakefulness, often leading to insomnia.

Additionally, restless leg syndrome (RLS) and periodic limb movement disorder (PLMD) are sleep movement disorders characterised by a distressing need to move one's legs or other limbs while sleeping. These disorders are linked to low dopamine levels. Since antipsychotics work by blocking D2 receptors, these medications can trigger or worsen RLS and PLMD.

Antipsychotic medication

The use of antipsychotics can increase sleep. However, the differences in subjective sleep outcomes between different antipsychotic medications are not entirely clear. Clozapine was associated with long sleep duration. Olanzapine and risperidone were associated with less sleep problems than patients using aripiprazole, quetiapine, or no antipsychotic medication. Aripiprazole and quetiapine were associated with more insomnia symptoms and poorer sleep quality. Patients without antipsychotic medications had poorer sleep quality than patients with antipsychotic use, and short sleep duration was common.

Frequently asked questions